| GLTO Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||
Below is a table of the GLTO shares outstanding history going back to 10/29/2020:
Also see: GLTO Market Cap History GLTO YTD Return |
As of 11/3/2025 Galecto has 1.33 million GLTO shares outstanding. Investors often track the GLTO shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows GLTO share count trends over time, with 20 historical shares outstanding datapoints presented, dating back to 10/29/2020.

| GLTO Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||
Below is a table of the GLTO shares outstanding history going back to 10/29/2020:
Also see: GLTO Market Cap History GLTO YTD Return |
| GLTO Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||
GLTO Historical Shares Outstanding: +6.16% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||
| GLTO Stock Price Chart |
| About Damora Therapeutics Inc |
| Galecto, Inc. is a clinical-stage biopharmaceutical company. Co. is focused on developing novel treatments for cancer and liver diseases. Co.'s pipeline consists small molecule drug candidates that target cancer and fibrosis signaling pathways, including an orally active galectin-3 inhibitor (GB1211) for the treatment of liver cirrhosis; an orally active galectin-3 inhibitor (GB1211) in combination with a checkpoint inhibitor for various oncology indications; and a preclinical dual inhibitor of ENL-YEATS and FLT3 (BRM-1420) for multiple genetic subsets of acute myeloid leukemia (AML). We show 20 historical shares outstanding datapoints in our coverage of GLTO's shares outstanding history. Understanding the changing numbers of GLTO shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like GLTO versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching GLTO by allowing them to research GLTO shares outstanding history as well as any other stock in our coverage universe. |
| GLTO Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| GLTO Share Performance |
| Shares Outstanding Peers |
| Galecto (GLTO) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
GLUE Shares Outstanding History GLXY Shares Outstanding History GLYC Shares Outstanding History GMED Shares Outstanding History GMTX Shares Outstanding History GNCA Shares Outstanding History GNLX Shares Outstanding History GNMK Shares Outstanding History GNMX Shares Outstanding History GNPX Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.